MedTrace Logo

Meditoxin® Treatment in Patients With Post Stroke Upper Limb Spasticity

NCT02757404 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 59

Last updated 2019-03-29

No results posted yet for this study

Summary

Botulinum Toxin for the Treatment of Post Stroke Upper Limb Spasticity.

Conditions

  • Muscle Spasticity

Interventions

DRUG

Ultrasonography guidance injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the ultrasonography guidance.

DRUG

Electrical stimulation guidance injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the electrical stimulation guidance.

DRUG

Manual needle placement injection of Meditoxin®.

Meditoxin® will be injected to upper limb spasticity by using the manual needle placement.

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Principal Investigators

  • MyungEun Chung · St. Paul's Hospital, The Catholic University of Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-30
Primary Completion
2016-08-16
Completion
2016-08-16

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02757404 on ClinicalTrials.gov